ТЕРАПИЯ ТРЕВОЖНЫХ РАССТРОЙСТВ У ПАЦИЕНТОВ С СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ (ОПЫТ ПРИМЕНЕНИЯ АФОБАЗОЛА)

According to modern researches data, patients with cardiovascular diseases often suffer from symptoms of anxiety-phobic, panic, somatoform disorders and hypochondria. One of the most common signs of psychopathological disorders in patients with cardiovascular diseases are anxiety symptoms. Developme...

Full description

Saved in:
Bibliographic Details
Main Author: В. Э. Медведев
Format: Article
Language:Russian
Published: SINAPS LLC 2013-06-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/197
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:According to modern researches data, patients with cardiovascular diseases often suffer from symptoms of anxiety-phobic, panic, somatoform disorders and hypochondria. One of the most common signs of psychopathological disorders in patients with cardiovascular diseases are anxiety symptoms. Development and introduction into clinical practice of new Russian anxiolytic Afobazol had opened new perspectives in the treatment of those patients.
ISSN:2226-6704
2411-6564